JD Health International (HKSE:06618) Cash And Cash Equivalents : HK$16,447 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is JD Health International Cash And Cash Equivalents?

JD Health International's quarterly cash and cash equivalents declined from Dec. 2022 (HK$20,902.36 Mil) to Jun. 2023 (HK$13,011.36 Mil) but then increased from Jun. 2023 (HK$13,011.36 Mil) to Dec. 2023 (HK$16,447.19 Mil).

JD Health International's annual cash and cash equivalents declined from Dec. 2021 (HK$21,124.87 Mil) to Dec. 2022 (HK$20,902.36 Mil) and declined from Dec. 2022 (HK$20,902.36 Mil) to Dec. 2023 (HK$16,447.19 Mil).

JD Health International Cash And Cash Equivalents Historical Data

The historical data trend for JD Health International's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International Cash And Cash Equivalents Chart

JD Health International Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

5,525.11

38,254.85

21,124.87

20,902.36

16,447.19

JD Health International Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial							21,124.87	19,538.23	20,902.36	13,011.36	16,447.19

JD Health International Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

JD Health International (HKSE:06618) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

JD Health International Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of JD Health International's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (HKSE:06618) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

JDHIY:USA JDHIF:USA 8ZN:Germany

Address

No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111

Website

https://ir.jdhealth.com

JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (HKSE:06618) Headlines

No Headlines